{
    "2P4.F": {
        "short_name": "BIOPORTO A/S B  DK 1",
        "long_name": "BioPorto A/S",
        "summary": "BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies for healthcare professionals in clinical and research settings worldwide. The company offers the neutrophil gelatinase-associated lipocalin (NGAL) test, a particle-enhanced turbidimetric test that measures NGAL that is used on clinical chemical analyzers; NGAL enzyme-linked immunosorbent assay (ELISA) kits for human use, as well as used in research and clinical practice; and MBL ELISA kit, which is based on MBL antibodies. It also provides monoclonal antibodies that cover various research disciplines, such as microbiology, immune deficiency, renal, peptide hormones, and plasma proteins. In addition, the company offers antigens, such as human monoclonal IgE. Further, it provides lateral flow platform gRAD for the development of assays. The company sells its products through own sales team, distributors, and OEM partnerships. BioPorto A/S was founded in 2000 and is headquartered in Hellerup, Denmark.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Denmark",
        "city": "Hellerup"
    },
    "BIOPOR.CO": {
        "short_name": "BioPorto A/S",
        "long_name": "BioPorto A/S",
        "summary": "BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies for healthcare professionals in clinical and research settings worldwide. The company offers the neutrophil gelatinase-associated lipocalin (NGAL) test, a particle-enhanced turbidimetric test that measures NGAL that is used on clinical chemical analyzers; NGAL enzyme-linked immunosorbent assay (ELISA) kits for human use, as well as used in research and clinical practice; and MBL ELISA kit, which is based on MBL antibodies. It also provides monoclonal antibodies that cover various research disciplines, such as microbiology, immune deficiency, renal, peptide hormones, and plasma proteins. In addition, the company offers antigens, such as human monoclonal IgE. Further, it provides lateral flow platform gRAD for the development of assays. The company sells its products through own sales team, distributors, and OEM partnerships. BioPorto A/S was founded in 2000 and is headquartered in Hellerup, Denmark.",
        "currency": "DKK",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "CPH",
        "market": "dk_market",
        "country": "Denmark",
        "city": "Hellerup"
    }
}